SPECT and PET imaging of brain tumors.

Brain Neoplasms/radionuclide imaging; Diagnosis, Differential; Humans; Radioactive Tracers; Radiopharmaceuticals/diagnostic use; Tomography, Emission-Computed/methods; Tomography, Emission-Computed, Single-Photon/methods

Abstract :

[en] The unique capacity of measuring or visualizing intracellular biochemical processes allows nuclear medicine techniques to determine functional and metabolic activities of various disorders. This article describes the critical role of single-photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging of brain tumors beyond what can be achieved by anatomic methods.

Disciplines :

Oncology
Radiology, nuclear medicine & imaging

Author, co-author :

Hustinx, Roland ; Université de Liège - ULiège > Département des sciences cliniques > Médecine nucléaire

Alavi, A.

Language :

English

Title :

SPECT and PET imaging of brain tumors.

Publication date :

1999

Journal title :

Neuroimaging Clinics of North America

ISSN :

1052-5149

Publisher :

W.B. Saunders

Volume :

Issue :

Pages :

751-66

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 28 January 2010

Statistics

Number of views

49 (2 by ULiège)

Number of downloads

2 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Alavi JB, Alavi A, Chawluk J, et al: Positron emission tomography in patients with glioma: A predictor of prognosis. Cancer 62:1074-1078, 1988
Alexander ED, Loeffler JS, Schwartz RB, et al: Thallium-201 technetium-99m HMPAO single-photon emission computed tomography (SPECT) imaging for guiding stereotactic craniotomies in heavily irradiated malignant glioma patients. Acta Neurochir 122:215-217, 1993
Ancri D, Basset JY, Lonchampt MF, et al: Diagnosis of cerebral lesions by thallium 201. Radiology 128: 417-422, 1978
Andrews DW, Das R, Kim S, et al: Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery 40:1323-1332, 1997
Bagni B, Pinna L, Tamarozzi R, et al: SPET imaging of intracranial tumours with 99Tcm-sestamibi. Nucl Med Commun 16:258-264, 1995
Baillet G, Albuquerque L, Chen Q, et al: Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21:1061-1066, 1994
Barker FG 2nd, Chang SM, Valk PE, et al: 18-FIuo-rodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 79: 115-126, 1997
Beauchesne P, Soler C, Maatougui K, et al: Is cerebral tomoscintigraphy with 99mTc-MIBI useful in the diagnosis of local recurrence in patients with malignant gliomas? Cancer Radiother 2:42-48, 1998
Bergstrom M, Muhr C, Jossan S, et al: Differentiation of pituitary adenoma and meningioma: Visualization with positron emission tomography and [HC]-L-de-prenyl. Neurosurgery 30:855-861, 1992
Bernât I, Toth G, Kovacs L: Tumour-like thallium-201 accumulation in brain infarcts, an unexpected finding on single-photon emission tomography [see comments]. Eur J Nucl Med 21:191-195, 1994
Biersack HJ, Coenen HH, Stocklin G, et al: Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT. J Nucl Med 30:110-112, 1989
Black KL, Hawkins RA, Kim KT, et al: Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71:342-346, 1989
Brismar T, Collins VP, Kesselberg M: Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 500:30-36, 1989
Brown RS, Wahl RL: Overexpression of Glut-1 glucose transporter in human breast cancer: An immu-nohistochemical study. Cancer 72:2979-2985, 1993
Brunetti A, Fulham MJ, Aloj L, et al: Decreased brain glucose utilization in patients with Crafting's disease. J Nucl Med 39:786-790, 1998
Buchpiguel CA, Alavi JB, Alavi A, et al: PET versus SPECT in distaguishing radiation necrosis from tumor recurrence in the brain [clinical conference]. J Nucl Med 36:159-164, 1995
Carvalho PA, Schwartz RB, Alexander ED, et al: Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77: 565-570, 1992
Chiù ML, Kronauge JF, Piwnica-Worms D: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisoni- trile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 31:1646-1653, 1990
D'Amico A, Messa C, Castagna A, et al: Diagnostic accuracy and predictive value of ""T1 SPECT for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun 18:741-750, 1997
D'Aquino S, Cicciarello R, D'Avella D, et al: Effect of x-radiation to brain on cerebral glucose utilization in the rat. J Neurosurg Sci 34:215-218, 1990
Davis WK, Boyko OB, Hoffman JM, et al: [18F]2-fluoro-2- deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia [see comments]. AJNR Am J Neuroradiol 14:515-523, 1993
Delbeke D, Meyerowitz C, Lapidus RL, et al: Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47-52, 1995
Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, et al: Uptake of the cation hexakis(2-methoxyisobutylisorurrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 50: 2198-2202, 1990
Derlon JM, Bourdet C, Bustany P, et al: [11C]L-methi-onine uptake in gliomas. Neurosurgery 25:720-728, 1989
Derlon JM, Petit-Taboue MC, Chapon F, et al: The in vivo metabolic pattern of low-grade brain gliomas: A positron emission tomographic study using "F-fluorodeoxyglucose and "C-L-memylmethionine [see comments]. Neurosurgery 40:276-288, 1997
De Witte O, Hildebrand J, Luxen A, et al: Acute effect of carmustine on glucose metabolism in brain and glioblastoma. Cancer 74:2836-2842, 1994
de Wolde H, Pruim J, Mastik MF, et al: Proliferative activity in human brain tumors: Comparison of his-topathology and L-[1-(11)C]tyrosine PET. J Nucl Med 38.1369-1374, 1997
Di Chiro G: Positron emission tomography using ["F] fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 22:360-371, 1987
Di Chiro G, DeLaPaz RL, Brooks RA, et al: Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32:1323-1329, 1982
Di Chiro G, Hatazawa J, Katz DA, et al: Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: A PET study. Radiology 164:521-526, 1987
Di Chiro G, Oldfield E, Wright DC, et al: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropatho-logic studies. AJR Am J Roentgenol 150:189-197, 1988
Dierckx RA, Martin JJ, Dobbeleir A, et al: Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 21:621-633, 1994
Doyle WK, Budinger TP, Valk PE, et al: Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 11:563-570, 1987
Ericson K, Blomqvist G, Bergstrom M, et al: Application of a kinetic model on the methionine accumulation in intracranial tumours studied with positron emission tomography. Acta Radiol 28:505-509, 1987
Ericson K, Lilja A, Bergstrom M, et al: Positron emission tomography with (11C]methyl)-L-methionine, [11C]D-glucose, and [ 68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 9:683-689, 1985
Fischman AJ, Thornton AF, Frosch MP, et al: FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. J Nucl Med 38:1027-1029, 1997
Fulham MJ, Melisi JW, Nishimiya J, et al: Neuroim-aging of juvenile pilocytic astrocytomas: An enigma [see comments]. Radiology 189:221-225, 1993
Goethals P, Lameire N, van Eijkeren M, et al: [Methyl-carbon- 11] thymidine for in vivo measurement of cell proliferation. J Nucl Med 37:1048-1052, 1996
Goldman S, Levivier M, Pirotte B, et al: Regional methionine and glucose uptake in high-grade gliomas: A comparative study on PET-guided stereotactic biopsy [published erratum appears in J Nucl Med 1997 Dec;38(12):2002]. J Nucl Med 38:1459-1462, 1997
Gorniak RI, Kramer EL, McMeeking AA, et al: Thallium-201 uptake in cytomegalovirus encephalitis. J Nucl Med 38:1386-1388, 1997
Griffeth LK, Rich KM, Dehdashti F, et al: Brain metastases from non-central nervous system tumors: Evaluation with PET [see comments]. Radiology 186:37-44, 1993
Haldemarm AR, Rosier H, Barth A, et al: Somatostatin receptor scintigraphy in central nervous system rumors: Role of blood-brain barrier permeability. J Nucl Med 36:403-410, 1995
Hara T, Kosaka N, Shinoura N, et al: PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 38:842-847, 1997
Hatazawa J, Ishiwata K, Itoh M, et al: Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography. J Nucl Med 30:1809-1813, 1989
Herholz K, Pietrzyk U, Voges J, et al: Correlation of glucose consumption and tumor cell density in astrocytomas: A stereotactic PET study. J Neurosurg 79:853-858, 1993
Hirano T, Otake H, Kazama K, et al: Technetium-99m(V)-DMSA and thallium-201 in brain rumor imaging: Correlation with histology and malignant grade. J Nucl Med 38:1741-1749, 1997
Hoffman JM, Hanson MW, Friedman HS, et al: FDG-PET in pediatric posterior fossa brain tumors. J Comput Assist Tomogr 16:62-68, 1992
Holthoff VA, Herholz K, Berthold F, et al: In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment. Cancer 72:1394-1403, 1993
Holzer T, Herholz K, Jeske J, et al: FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 17:681-687, 1993
Hubner KF, Thie JA, Smith GT, et al: Positron emission tomography with 1-aminocyclobutane-l-[11C]carboxylic acid for detecting recurrent brain tumors. Clin Positron Imaging 1:165-173, 1998
Ishibashi M, Taguchi A, Sugita Y, et al: Thallium-201 in brain tumors: Relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 36:2201-2206, 1995
Ishikawa M, Kikuchi H, Miyatake S, et al: Glucose consumption in recurrent gliomas. Neurosurgery 33:28-33, 1993
Ishiwata K, Kubota K, Murakami M, et al: Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 34:1936-1943, 1993
Ishizu K, Nishizawa S, Yonekura Y, et al: Effects of hyperglycemia on FDG uptake in human brain and glioma [see comments]. J Nucl Med 35:1104-1109, 1994
Ito M, Patronas NJ, Di Chiro G, et al: Effect of moderate level x-radiation to brain on cerebral glucose utilization. J Comput Assist Tomogr 10:584-588, 1986
Janus TJ, Kim EE, Tilbury R, et al: Use of [18F] fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 33:540-548, 1993
Kallen K, Heiling M, Andersson AM, et al: Preoperative grading of glioma malignancy with thaUium-201 single-photon emission CT: Comparison with conventional CT. AJNR Am J Neuroradiol 17:925-932, 1996
Kallen K, Heiling M, Andersson AM, et al: Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT. J Neurol Neurosurg Psychiatry 63:569-574, 1997
Kao CH, Chang Lai SP, Chieng PU, et al: Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: Relation to patient prognosis and chemotherapy response - a preliminary report. Cancer 83:64-68, 1998
Kaplan WD, Takvorian T, Morris JH, et al: Thallium-201 brain rumor imaging: A comparative study with pathologic correlation. J Nucl Med 28:47-52, 1987
Kaschten B, Stevenaert A, Sadzot B, et al: Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methio-nine. J Nucl Med 39:778-785, 1998
Kassis AI, Van den Abbeele AD, Wen PY, et al: Specific uptake of the auger electron-ernitting thymidine analogue 5-[123I/125I]iodo-2′- deoxyuridine in rat brain tumors: Diagnostic and therapeutic implications in humans. Cancer Res 50:5199-5203, 1990
Kawai K, Fujibayashi Y, Saji H, et al: A strategy for the study of cerebral amino add transport using io-dine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine. J Nucl Med 32:819-824, 1991
Kessler LS, Ruiz A, Donovan Post MI, et al: Thallium-201 brain SPECT of lymphoma in AIDS patients: Pitfalls and technique optimization. AJNR Am J Neuroradiol 19:1105-1109, 1998
Kim CK, Alavi JB, Alavi A, et al: New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neuro-oncol 10:85-91, 1991
Kim EE, Chung SK, Haynie TP, et al: Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 12:269-279, 1992
Kim KT, Black KL, Marciano D, et al: Thallium-201 SPECT imaging of brain tumors: Methods and results [see comments]. J Nucl Med 31:965-969, 1990
Kincaid PK, El-Saden SM, Park SH, et al: Cerebral gangliogliomas: Preoperative grading using FDG-PET and 201TI-SPECT [see comments]. AJNR Am J Neuroradiol 19:801-806, 1998
Klutmann S, Bohuslavizki KH, Brenner W, et al: Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningiomas. J Nucl Med 39:1913-1917, 1998
Kostakoglu L, Guc D, Canpinar H, et al: P-glycopro-tein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy. J Nucl Med 39:1191-1197, 1998
Kosuda S, Fujii H, Aoki S, et al: Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiat Oncol Biol Phys 30:1201-1206, 1994
Krishna L, Slizofski WJ, Katsetos CD, et al: Abnormal intracerebral thallium localization in a bacterial brain abscess. J Nucl Med 33:2017-2019, 1992
Kuwert T, Morgenroth C, Woesler B, et al: Uptake of iodine-123-alpha- methyl tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 23:1345-1353, 1996
Kuwert T, Probst-Cousin S, Woesler B, et al: Iodine-123-alpha-methyl tyrosine in gliomas: Correlation with cellular density and proliferative activity. J Nucl Med 38:1551-1555, 1997
Langen KJ, Clauss RP, Holschbach M, et al: Comparison of iodotyrosines and methionine uptake in a rat glioma model. J Nucl Med 39:1596-1599, 1998
Langen KJ, Coenen HH, Roosen N, et al: SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: Comparison with PET, 124IMT and first clinical results. J Nucl Med 31:281-286, 1990
Langen KJ, Roosen N, Coenen HH, et al: Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: Competition with natural L-amino acids [see comments]. J Nucl Med 32:1225-1229, 1991
Langen KJ, Ziemons K, Kiwit JC, et al: 3-[123I]iodo-alpha- methyltyrosine and [methyP'Cl-L-methionine uptake in cerebral gliomas: A comparative study using SPECT and PET. J Nucl Med 38:517-522, 1997
Lee JD, Kim DI, Lee JT, et al: Indium-111-pentetreo-tide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI. J Nucl Med 36:537-541, 1995
Levivier M, Goldman S, Pirotte B, et al: Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F] fluorodeoxyglucose. J Neurosurg 82:445-452, 1995
Lorberboym M, Mandell LR, Mosesson RE, et al: The role of thallium-201 uptake and retention in intracranial rumors after radiotherapy. J Nucl Med 38:223-226, 1997
Lorberboym M, Wallach F, Estok L, et al: Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonma-lignant lesions in AIDS patients. J Nucl Med 39:1366-1369, 1998
Lucignani G, Losa M, Moresco RM, et al: Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethyl-spiperone. Eur J Nucl Med 24:1149-1155, 1997
Maffioli L, Gasparini M, Chiti A, et al: Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours. Eur J Nucl Med 23:308-311, 1996
Mankoff DA, Shields AF, Graham MM, et al: Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: Compartmental model and mathematical analysis. J Nucl Med 39:1043-1055, 1998
Maria BL, Drane WB, Quisling RJ, et al: Correlation between gadolinium-diethylenetriaminepentaacetic acid contrast enhancement and thallium-201 chloride uptake in pediatric brainstem glioma. J Child Neurol 12:341-348, 1997
Marriott CJ, Thorstad W, Akabani G, et al: Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-la-beled antibody for primary brain tumors. J Nucl Med 39:1376-1380, 1998
Matsumoto T, Tani E, Kaba K, et al: Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurg 74:460-466, 1991
Mineura K, Sasajima T, Kowada M, et al: Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73:2386-2394, 1994
Mogard J, Kihlstrom L, Ericson K, et al: Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: Diagnosis with PET-FDG. J Comput Assist Tomogr 18:177-181, 1994
Moretti JL, Duran Cordobes M, Starzec A, et al: Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. J Nucl Med 39:1214-1218, 1998
Mousseau M, Chauvin C, Nissou MF, et al: A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours. Eur J Cancer 29A:753-759, 1993
Muhr C, Bergstrom M: Positron emission tomography applied in the study of pituitary adenomas. J Endocrinol Invest 14:509-528, 1991
CDoherty MJ, Barrington SF, Campbell M, et al: PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 38:1575-1583, 1997
Ogawa T, Inugami A, Hatazawa J, et al: Clinical positron emission tomography for brain tumors: Comparison of fludeoxyglucose F 18 and L-methyl-"C-methionine. AJNR Am J Neuroradiol 17:345-353, 1996
Ogawa T, Kanno I, Hatazawa J, et al: Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 14:101-110, 1994
Ogawa T, Kanno I, Shishido F, et al: Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-"C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 32:197-202, 1991
Ogawa T, Miura S, Murakami M, et al: Quantitative evaluation of neutral amino acid transport in cerebral gliomas using positron emission tomography and fluorine-18 fluorophenylalanine. Eur J Nucl Med 23:889-895, 1996
Ogawa T, Shishido F, Kanno I, et al: Cerebral glioma: Evaluation with methionine PET [see comments]. Radiology 186:45-53, 1993
Ohte H, Endo K, Fujita T, et al: Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent. Nucl Med Com-mun 9:105-116, 1988
Olivero WC, Dulebohn SC, Lister JR: The use of PET in evaluating patients with primary brain rumours: Is it useful? J Neurol Neurosurg Psychiatry 58:250-252, 1995
Oriuchi N, Tamura M, Shibazaki T, et al: Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: Relationship to histologic grade, prognosis and proliferative activities [see comments]. J Nucl Med 34:2085-2089, 1993
Oriuchi N, Tomiyoshi K, Inoue T, et al: Independent thallium-201 accumulation and fluorine-18-fluoro-deoxyglucose metabolism in glioma. J Nucl Med 37:457-462, 1996
OTuama LA, Packard AB, Treves ST: SPECT imaging of pediatric brain tumor with hexakis (methoxyiso-butylisonitrile) technetium (I). J Nucl Med 31:2040-2041, 1990
O'Tuama LA, Treves ST, Larar JN, et al: Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain rumors: A within-subject comparison. J Nucl Med 34:1045-1051, 1993
Packard AB, Kronauge IF, Limpa-Amara N, et al: Tumor uptake of Tc-MIBI and 201T1 by a 9L gliosar-coma brain rumor model in rats. Nucl Med Biol 20:773-776, 1993
Patronas NJ, Brooks RA, DeLaPaz RL, et al: Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR Am J Neuroradiol 4:533-535, 1983
Patronas NJ, Di Chiro G, Brooks RA, et al: Work in progress: [ 18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 144:885-889, 1982
Patronas NJ, Di Chiro G, Kufta C, et al: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62:816-822, 1985
Pirotte B, Goldman S, Bidaut LM, et al: Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy. Acta Neurochir (Wien) 134:79-82, 1995
Pirotte B, Goldman S, David P, et al: Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18] fluorodeoxyglucose and [C-11]me-thionine. Acta Neurochir Suppl 68:133-138, 1997
Piwnica-Worms D, Kronauge JF, Chiu ML: Uptake and retention of hexakis (2-methoxyisobutyl isoni-trile) technerium (I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence. Circulation 82:1826-1838, 1990
Piwnica-Worms D, Rao W, Kronauge JF, et al: Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 34:12210-12220, 1995
Powe JE, Alavi J, Alavi A, et al: Cerebral metabolic changes in patients with brain tumors demonstrated by positron emission tomography. J Neuroimag 2:1-7, 1992
Pruim J, Willemsen AT, Molenaar WM, et al: Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate. Radiology 197:221-226, 1995
Rao W, Chiu ML, Kronauge JF, et al: Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 35:510-515, 1994
Reivich M, Alavi A, Wolf A, et al: Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F] fluorodeoxygIucose and [11C]deoxyglucose. J Cereb Blood How Metab 5:179-192, 1985
Reubi JC, Horisberger U, Lang W, et al: Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol 134:337-344, 1989 .
Reubi JC, Maurer R, Klijn JG, et al: High incidence of somatostatin receptors in human meningiomas: Biochemical characterization. J Clin Endocrinol Metab 63:433-438, 1986
Ricci PE, Karis JP, Heiserman JE, et al: Differentiating recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography? [see comments]. AJNR Am J Neuroradiol 19:407-413, 1998
Roelcke U: PET: Brain tumor biochemistry. J Neu-rooncol 22:275-279, 1994
Roelcke U, Blasberg RG, von Ammon K, et al: Dexa-methasone treatment and plasma glucose levels: Relevance for fluorine-18-fluorodeoxy glucose uptake measurements in gliomas. J Nucl Med 39:879-884, 1998
Roelcke U, Radu E, Ametamey S, et al: Association of rubidium and C-methionine uptake in brain tumors measured by positron emission tomography. J Neurooncol 27:163-171, 1996
Roelcke U, Radu EW, von Ammon K, et al: Alteration of blood-brain barrier in human brain tumors: Comparison of [18F] fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET. J Neurol Sci 132:20-27, 1995
Rollins NK, Lowry PA, Shapiro KN: Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. Pediatr Neurosurg 22:8-14, 1995
Rosenfeld SS, Hoffman JM, Coleman RE, et al: Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 33:532-536, 1992
Rozental JM, Cohen JD, Mehta MP, et al: Acute changes in glucose uptake after treatment: The effects of carmustine (BCNU) on human glioblastoma multiforme. J Neurooncol 15:57-66, 1993
Rozental JM, Levine RL, Mehta MP, et al: Early changes in tumor metabolism after treatment: The effects of stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 20:1053-1060, 1991
Rozental JM, Levine RL, Nickles RJ: Changes in glucose uptake by malignant gliomas: Preliminary study of prognostic significance. J Neurooncol 10:75-83, 1991
Sasaki M, Ichiya Y, Kuwabara Y, et al: Ring-like uptake of FDG in brain abscess: A PET study. J Comp Assist Tomogr 14:486-487, 1990
Sasaki M, Kuwabara Y, Yoshida T, et al: A comparative study of thalhum-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumors. Eur J Nucl Med 25:1261-1269, 1998
Schifter T, Hoffman JM, Hanson MW, et al: Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 17:509-561, 1993
Schillaci O, Danieli R, Tavolaro R, et al: Tc-99m tetro-fosmin accumulation in lung cancer and its metastases. Clin Nucl Med 22:46-47, 1997
Schmidt M, Scheidhauer K, Luyken C, et al: Somatostatin receptor imaging in intracranial tumours. Eur J Nucl Med 25:675-686, 1998
Schwartz RB, Carvalho PA, Alexander ED, et al: Radiation necrosis vs high-grade recurrent glioma: Differentiation by using dual-isotope SPECT with 201T1 and 99mTc-HMPAO. AJNR Am J Neuroradiol 12:1187-1192, 1991
Schwartz RB, Holman BL, Polak JF, et al: Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: Association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 89:60-68, 1998
Shih WJ, Kadzielawa K, Lee C, et al: Tc-99m sestamibi uptake by cerebellar metastasis from bronchogenic carcinoma [see comments]. Clin Nucl Med 18:887-890, 1993
Soricelli A, Cuocolo A, Varrone A, et al: Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: Comparison with thallium-201 imaging. J Nucl Med 39:802-806, 1998
Taki J, Sumiya H, Asada N, et al: Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. J Nucl Med 39:1179-1184, 1998
Tamura M, Shibasaki T, Zama A, et al: Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride. Neuroradiology 40:210-215, 1998
Tedeschi E, Soricelli A, Brunetti A, et al: Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas. Eur J Nucl Med 23:1478-1484, 1996
Tjuvajev JG, Macapinlac HA, Daghighian F, et al: Imaging of brain tumor proliferative activity with io-dine-131-iododeoxyuridine. J Nucl Med 35:1407-1417, 1994
Tonami N, Matsuda H, Ooba H, et al: ThaUium-201 accumulation in cerebral candidiasis: Unexpected finding on SPECT. Clin Nucl Med 15:397-400, 1990
Tyler JL, Diksic M, Villemure JG, et al: Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 28:1123-1133, 1987
Ueda T, Kaji Y, Wakisaka S, et al: Time sequential single photon emission computed tomography studies in brain tumour using thallium-201. Eur J Nucl Med 20:138-145, 1993
Valk P, Budinger T, Levin V, et al: PET of malignant cerebral activity and correlation with clinical outcome. J Neurosurg 69:830-838, 1988
Valk PE, Budinger TF, Levin VA, et al: PET of malignant cerebral tumors after interstitial brachytherapy: Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 69:830-838, 1988
Vander Borght T, Lambotte L, Pauwels S, et al: Noninvasive measurement of liver regeneration with positron emission tomography and [2-11C]thymidine. Gastroenterology 101:794-799, 1991
Vertosick FT Jr, Selker RG, Grossman SJ, et al: Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 34:396-401, 1994
Vulringer K, Jager H, Dichgans M, et al: Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr 19:532-536, 1995
Wang GJ, Volkow ND, Lau YH, et al: Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy. A preliminary study. J Comput Assist Tomogr 20:709-714, 1996
Warburg O: The Metabolism of Tumors. London, Arnold Constable, 1930
Weber W, Bartenstein P, Gross MW, et al: Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 38:802-808, 1997
Wienhard K, Herholz K, Coenen HH, et al: Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine [see comments]. J Nucl Med 32:1338-1346, 1991
Willemsen AT, van Waarde A, Paans AM, et al: In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET. J Nucl Med 36:411-419, 1995
Woesler B, Kuwert T, Morgenroth C, et al: Non-invasive grading of primary brain tumours: Results of a comparative study between SPET with 18I-alpha-methyl tyrosine and PET with 18F-deoxyglucose. Eur J Nucl Med 24:428-434, 1997
Yokogami K, Kawano H, Moriyama T, et al: Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: Is it possible to predict the response to chemotherapy in patients with gliomas by means of 99Tc-sestamibi SPET? Eur J Nucl Med 25:401-409, 1998
Yoshii Y, Satou M, Yamamoto T, et al: The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 20:39-45, 1993
Zingale A, Musumeci S, Nicoletti G, et al: Thallium-201-SPECT and 99Tc-HM-PAO SPECT imaging to study functionally cerebral supratentorial neoplasms: The biological basis of the functional imaging interpretation. J Neurosurg Sri 39:227-235, 1995.